Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac action potential propagation refers to the physiological process by which electrical impulses, generated by ion fluxes across the cardiac cell membrane, are transmitted from one cardiac myocyte to another throughout heart tissue. This propagation is crucial for coordinated contraction of the heart and is determined by complex interactions among ion channels, gap junctions, the tissue structure of the heart, and the local microenvironment. While propagating action potentials are essential for normal cardiac function, abnormalities in this process can contribute to arrhythmias and other heart diseases. This entity is not a discrete molecule, protein, or receptor, but rather an integrative physiological phenomenon arising from multiple molecular mechanisms, especially the coordinated action of various ion channels (e.g., sodium, potassium, calcium channels), cell-cell junctional communication (gap junctions), and tissue-level properties[1][3][8][10]. Detailed evaluation: - "Cardiac action potential propagation" is not a molecule, protein, enzyme, transporter, or receptor, but a physiological process describing the electrical conduction through cardiac tissue[1][3][4][10]. - No unique canonical name, abbreviation, or specific molecular classification fits (e.g., unlike "Sodium channel protein type 1 subunit alpha" or "Connexin 43"). - The primary molecular underpinnings involve clusters of cardiac ion channels (Na⁺, K⁺, Ca²⁺), gap junctions (primarily connexins), and supporting cellular architecture, but none individually embody "cardiac action potential propagation"[1][3][7][8]. - As such, it cannot be considered a conventional drug target. Instead, multiple molecules and pathways involved in this process may be drug targets (e.g., sodium channels for antiarrhythmics), but not the propagation process itself. - If structured or drug-target-centric information is required, focus should shift to individual ion channels (SCN5A, KCNQ1), connexin proteins (such as Connexin 43), or defined components of the cardiac conduction system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac action potential propagation.